news roundup
The acquisition combines Exco's patient engagement and BYOD solutions with ERT's established science-driven solutions.
| advertisment
Read this interview with IBM company (eClinical Division), discusses risk-based monitoring (RBM) and how the company is innovating a 25-year-old manual process to enable better monitoring decisions.  Learn more |
A European research hospital has selected OmniComm's TrialMaster EDC to integrate privacy-protected patient data from the hospital's electronic health records, for an infectious disease observational study.
Almac Clinical Technologies will provide IRT solutions to inVentiv clients, and inVentiv Health's IRT specialists will also join Almac Clinical Technologies' consultancy team.
|
|
|
| advertisment
 Click here
and press play in our video player to watch a short video about Covance Xcellerate Trial Management, a single package of 4 software solutions that work together to create a skeletal system for more efficient, effective trial management.
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
Leveraging data to support evidence-based enrollment planning and site identification for clinical studies is a hot topic among companies looking to streamline study start-up. Accessing accurate metrics to support study planning and to predict successful site recruitment is critical to this evidence-based approach.
CenterWatch conducted an assessment online between June and September 2016 among a global community of sites. The survey marks a first-ever effort to measure the quality of IRB-site relationships, with the results outlined in this article.
|
|
| advertisment
Pediatric Oncology Trials: Changes on the Horizon
Live Webinar: Tuesday, December 13 at 2:00pm EST
 Register now |
| advertisment
The Evolution of Regulatory Affairs
On Demand
 Learn more |
|
Blog Posts
The 21st Century Cures bill includes important provisions that can help FDA hire the scientists and experts it needs to evaluate new medical products.
Europe's Organization for Economic Co-operation and Development reports extensively on socioeconomic determinants of health, equality of access and resilience of healthcare systems, but there is little appreciation of any contribution that drug research might play in maintaining and improving the health status of Europeans.
|
|
| advertisment
Simplifying the complexities of global rare disease drug development
On Demand
 Learn more |
|
Oncology
KMR Group recently released its 2016 Best Places for Clinical Research report series, which highlights the strengths and weaknesses of nearly 100 countries for several different therapy areas and diseases, including oncology.
INC Research was selected by Leukemia & Lymphoma Society to manage its precision medicine Master Trial for the treatment of acute myeloid leukemia (AML).
|
|
Schulman IRB's Central Oncology Review division provides collaborative, flexible central IRB review services for cancer research centers and their IRBs.
Regulatory agencies have streamlined pathways to move drugs with enhanced activity on progression free survival (PFS) and response endpoints to ultimately reach patients faster by accelerating approval and breakthrough status programs.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
